Clinical Trial Update: Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a Phase 3 study comparing the investigational agent U0267 to vehicle in plaque-type psoriasis; the study (NCT006…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• U0267

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-08